SCHEMBL7782701

SCHEMBL7782701

CC(C)[C@@H](NC(=O)OCc1ccccc1)C(=O)OCC(C)(C)C(=O)OCCl.CC(C)[C@@H](NC(=O)OCc1ccccc1)C(=O)OCC(C)(C)C(=O)OCI

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
RAB9A P51151 1/20 0.46
CTSB P07858 4/20 0.46
CTSL P07711 4/20 0.46
CTSK P43235 3/20 0.46
CTSS P25774 3/20 0.46
SYK P43405 1/20 0.45
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
CAPN1 P07384 2/20 0.43
ELANE P08246 2/20 0.43
LMNA P02545 1/20 0.43
CCR1 P32246 2/20 0.43
PRTN3 P24158 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3730098 0.96 CTSB (0.49) CYP3A4CYP2D6CYP2C9CYP2C19RAB9A
SCHEMBL3727071 0.96 CTSB (0.49) CYP3A4CYP2D6CYP2C9CYP2C19RAB9A
SCHEMBL3740281 0.95 CTSB (0.50) CYP3A4CYP2D6CYP2C9CYP2C19RAB9A
SCHEMBL3728988 0.95 CTSB (0.50) CYP3A4CYP2D6CYP2C9CYP2C19RAB9A
SCHEMBL7790292 0.89 CTSB (0.44) CYP3A4CYP2D6CYP2C9CYP2C19RAB9A
SCHEMBL3731597 0.89 CYP3A4 (0.59) CYP3A4CYP2D6CYP2C9CYP2C19RAB9A
SCHEMBL6476348 0.86 CYP3A4 (0.59) CYP3A4CYP2D6CYP2C9CYP2C19RAB9A
SCHEMBL3740379 0.86 CYP3A4 (0.59) CYP3A4CYP2D6CYP2C9CYP2C19RAB9A
SCHEMBL3739712 0.84 CTSB (0.46) CYP3A4CYP2D6CYP2C9CYP2C19RAB9A
SCHEMBL3725744 0.84 CTSK (0.54) CTSBCTSLCTSKCTSSMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1150956-A1 NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS MEDIVIR AB (SE) 2001-11-07 EP disclosed
EP-1054891-A1 PRODRUGS MEDIVIR AB (SE) 2000-11-29 EP disclosed
WO-2000047561-A1 NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS MEDIVIR AB (SE) 2000-08-17 WO disclosed
WO-1999041275-A1 PRODRUGS MEDIVIR AB (SE) 1999-08-19 WO disclosed